Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure
- PMID: 14964574
- DOI: 10.2169/internalmedicine.43.9
Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure
Abstract
There are many different glomerular disorders, including glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis. However, once glomerular damage reaches a certain threshold, the progression of renal disease is consistent and irreversible. Recent studies emphasized the crucial role of tubulointerstitial injury as a mediator of progression of kidney disease. One common mechanism that leads to renal failure via tubulointerstitial injury is massive proteinuria. Accumulating evidence suggests critical effects of filtered macromolecules on tubular cells, including lysosomal rupture, energy depletion, and tubular injury directly induced by specific components such as complement components. Another common mechanism is chronic hypoxia in the tubulointerstitium. Tubulointerstitial damage results in the loss of peritubular capillaries, impairing blood flow delivery. Interstitial fibrosis also impairs oxygen diffusion and supply to tubular cells. This induces chronic hypoxia in this compartment, rendering a vicious cycle. Development of novel therapeutic approaches against these final common pathways will enable us to _target any types of renal disease.
Similar articles
-
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.J Am Soc Nephrol. 2006 Jan;17(1):17-25. doi: 10.1681/ASN.2005070757. Epub 2005 Nov 16. J Am Soc Nephrol. 2006. PMID: 16291837 Review.
-
Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.Nephron Exp Nephrol. 2004;98(1):e8-12. doi: 10.1159/000079927. Nephron Exp Nephrol. 2004. PMID: 15361693 Review.
-
Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors?J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S186-91. doi: 10.1097/01.asn.0000070032.58017.20. J Am Soc Nephrol. 2003. PMID: 12819326 Review.
-
[The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].Przegl Lek. 1996;53(5):443-53. Przegl Lek. 1996. PMID: 8754411 Review. Polish.
-
Spread of glomerular to tubulointerstitial disease with a focus on proteinuria.Ann Anat. 2010 May 20;192(3):125-32. doi: 10.1016/j.aanat.2010.03.003. Epub 2010 Apr 3. Ann Anat. 2010. PMID: 20400279 Review.
Cited by
-
RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats.PLoS One. 2016 Jun 9;11(6):e0156729. doi: 10.1371/journal.pone.0156729. eCollection 2016. PLoS One. 2016. PMID: 27281190 Free PMC article.
-
Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.Proteomics Clin Appl. 2009 Aug 26;3(9):1029-1043. doi: 10.1002/prca.200800243. Proteomics Clin Appl. 2009. PMID: 20161589 Free PMC article.
-
Proteinuria and hyperglycemia induce endoplasmic reticulum stress.J Am Soc Nephrol. 2008 Nov;19(11):2225-36. doi: 10.1681/ASN.2007121313. Epub 2008 Sep 5. J Am Soc Nephrol. 2008. PMID: 18776125 Free PMC article.
-
HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis.Am J Physiol Renal Physiol. 2008 Sep;295(3):F707-16. doi: 10.1152/ajprenal.90240.2008. Epub 2008 Jul 2. Am J Physiol Renal Physiol. 2008. PMID: 18596079 Free PMC article.
-
Yiqihuoxue Formula Activates Autophagy and Offers Renoprotection in a Rat Model of Adenine-Induced Kidney Disease.Evid Based Complement Alternat Med. 2019 Dec 24;2019:3423981. doi: 10.1155/2019/3423981. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31949466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
